e-Edition
Obituaries
Special Sections
Special Occasions
Contact

Subscribe
Paywall Login
Login to Comment
Register

December 11th, 2017

jobs

homes

Home
News
Sports
Business
Entertainment
Classifieds
Commentary

Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Biohaven Ltd. Common Shares (NY:BHVN)

9.930 UNCHANGED

Streaming Delayed Price Updated: 7:00 PM EST, Jan 5, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Biohaven Ltd. Common Shares

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Why Biohaven Pharmaceuticals Stock Crumbled On This Premium Deal With Pfizer ↗

November 09, 2021

Biohaven will receive up to $1.24 billion in payments under a deal for Nurtec ODT.

Via Investor's Business Daily

Jim Cramer: MGM Resorts Has Good Top Management ↗

November 09, 2021

On CNBC’s "Mad Money Lightning Round," Jim Cramer said MGM Resorts International (NYSE: MGM) has a lot of good top management. With Wynn Resorts, Limited (NASDAQ...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 09, 2021

Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...

Via Benzinga

Analyst Ratings For Biohaven Pharma Hldgs ↗

October 19, 2021

Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the f...

Via Benzinga

Cramer Likes American Eagle Outfitters And These 2 Pharma Stocks ↗

October 18, 2021

On CNBC’s “

Via Benzinga

Where Biohaven Pharma Hldgs Stands With Analysts ↗

September 13, 2021

Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the ...

Via Benzinga

The Week Ahead In Biotech (Aug. 8-14): Jazz Pharma FDA Decision, Earnings Deluge and IPOs In The Spotlight ↗

August 08, 2021

Biopharma stocks ended higher for the week ending Aug. 6, as the sector latched on to the optimism that was evident in the broader markets. Earnings continued to flow in,...

Via Benzinga

Where Biohaven Pharma Hldgs Stands With Analysts ↗

August 03, 2021

Within the last quarter, Biohaven Pharma Hldgs (NYSE:BHVN) has observed the ...

Via Benzinga

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data ↗

November 09, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...

Via Benzinga

Where Biohaven Pharma Hldgs Stands With Analysts ↗

October 06, 2021

Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:BHV...

Via Benzinga

Stocks That Hit 52-Week Highs On Thursday ↗

July 29, 2021

Thursday's morning session saw 167 companies set new 52-week highs. Points of Interest: ASML Holding (NASDAQ:ASML) was the largest company by market cap to set a new...

Via Benzinga

Analyst Ratings For Biohaven Pharma Hldgs ↗

July 16, 2021

Analysts have provided the following ratings for Biohaven Pharma Hldgs (NYSE:

Via Benzinga

The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More ↗

November 08, 2021

Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...

Via Benzinga

10 Biggest Price Target Changes For Wednesday ↗

October 06, 2021

Goldman Sachs lowered the price target on Nucor Corporation (NYSE:

Via Benzinga

The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal ↗

October 06, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (...

Via Benzinga

What 7 Analyst Ratings Have To Say About Biohaven Pharma Hldgs ↗

October 05, 2021

Biohaven Pharma Hldgs (NYSE:BHVN) has observed the following analyst ratings...

Via Benzinga

Biohaven Surges To Record High As Kardashian-Backed Migraine Drug Outperforms — Again ↗

October 05, 2021

This company sells a migraine medicine backed by Khloe Kardashian.

Via Investor's Business Daily

The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO ↗

October 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks...

Via Benzinga

Why Are Biohaven Shares Trading Lower On Monday? ↗

September 27, 2021

Biohaven Pharmaceutical Holding Company Ltd (NYSE: BHVN) has announced results from a focused analysis of verdiperstat trial in verdiperstat in multiple system...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 27, 2021

Gainers Syndax Pharmaceuticals (NASDAQ:SNDX) shares moved upwards by 8.94% to $20.48 during Monday's pre-market session. The company's market cap stands at $995.9...

Via Benzinga

Cramer Gives His Opinion On Service Corporation, Vertex And More ↗

September 10, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said he isn't happy with the way Inseego Corp (NASDAQ: INSG) acts. He is beginning to believe it deserves to...

Via Benzinga

Cramer Gives His Opinion On Zillow, SoFi And More ↗

August 12, 2021

On CNBC's "Mad Money Lightning Round," Jim Cramer said this is a decent level at which to buy Zillow Group Inc Class A (NASDAQ: ZG) with mortgage rates so low....

Via Benzinga

Biohaven Pharma: Q2 Earnings Insights ↗

August 09, 2021

Shares of Biohaven Pharma Hldgs (NYSE:BHVN) rose 0.8% in pre-market trading after the company reported Q2 results. Quarterly Results Earnings per share decreased 2.75% year...

Via Benzinga

The Daily Biotech Pulse: Cellect Jumps On First Apograft Transplantation, AstraZeneca, European Commission Bury Legal Hatchet, Cassava Defends Itself ↗

September 03, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 2) Abbott Laboratories (NYSE:...

Via Benzinga

The Daily Biotech Pulse: FDA Nod For Merck-Eisai, Seres' Ulcerative Colitis Drug Flunks Midstage Study, Pfizer To Invest In Arvinas, AbSci IPO ↗

July 22, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) Biohaven Pharmaceutical...

Via Benzinga

The Daily Biotech Pulse: Assembly Bio Halts HBV Study, Moderna Initiates Submission For COVID-19 Booster Dose, FDA Nod For BeiGene, Tiziana Out-Licenses Foralumab ↗

September 02, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 1) AbbVie Inc. (NASDAQ: ABBV...

Via Benzinga

Will This Biopharma Company Continue to Crush It? ↗

July 17, 2021

Migraine sufferers certainly hope so.

Via The Motley Fool

The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering ↗

September 01, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU...

Via Benzinga

The Daily Biotech Pulse: Erytech Jumps On Fast Track Designation, GlaxoSmithKline FDA Nod, Alnylam's Clinical Collaboration, 4 IPOs ↗

July 30, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 29) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay ↗

July 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 20) Alnylam Pharmaceuticals,...

Via Benzinga

< Previous 1 2

...

8 9 10 11 12 13 14 15 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

More ways to get to us

Facebook

Twitter

YouTube

ePaper Login
Subscribe
Subscription Services
Archive

About Us

The Lethbridge Herald
Other Publications
Food For Thought

Contact
Careers

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

Advertising
Terms and Conditions & Privacy Policy